Related Experiment Video
Updated: Oct 25, 2025

06:15
Author Spotlight: Anterior HR-OCT as a Non-Invasive Tool for Characterizing Ocular Surface Squamous Neoplasia
Published on: August 9, 2024
1.5K
MICROENVIRONMENT ALTERATIONS IN CONJUNCTIVAL NEOPLASTIC LEOSIONS WITH DIFFERENT PROLIFERATION-APOPTOTIC
N Nikolaishvili1, G Chichua1, T Muzashvili2
11The New Vision University; Georgia.
Georgian Medical News
|August 8, 2021
Summary
Tumor infiltrating lymphocytes (TILs) and tumor associated neutrophils (TANs) increase in conjunctival lesions. Their numbers correlate with higher proliferation and p53 mutations in cancer progression.
Area of Science:
- Ophthalmology
- Oncology
- Immunology
Background:
- Tumor infiltrating lymphocytes (TILs) and tumor associated neutrophils (TANs) are crucial in malignant tumor progression.
- Understanding their role in conjunctival lesions is vital for early diagnosis and treatment.
Purpose of the Study:
- To analyze the distribution and characteristics of TILs and TANs in various conjunctival lesions.
- To investigate the correlation between immune cell infiltration and lesion progression markers.
Main Methods:
- Digital pathology software (QuPath) was used to evaluate H&E stained sections of normal conjunctiva, actinic keratosis, pterygia, conjunctival intraepithelial neoplasias (CoIN1-3), and conjunctival squamous cell carcinoma (CSCC).
- Immunohistochemistry was performed to assess markers including Ki67, Bcl2, p53, CD3, CD8, and Foxp3.
- Quantitative analysis of TILs and TANs distribution was conducted.
Main Results:
- A significant increase in TILs and TANs was observed during the progression of conjunctival intraepithelial lesions.
- The counts of TILs and TANs showed a significant correlation with a higher proliferation index.
- Immune cell infiltration correlated with a lower apoptotic index and p53 mutation status.
Conclusions:
- TILs and TANs infiltration increases with the progression of conjunctival lesions, including precancerous and cancerous stages.
- Immune cell presence is linked to key indicators of tumor aggressiveness, such as proliferation and p53 mutations.
- These findings highlight the potential of TILs and TANs as biomarkers in conjunctival disease.

